Have you thought about

checking our FAQ ?

Who can benefit from the NFI services?

4 specific cases:
  • Foreign companies in all sectors looking to expand in Hauts-de-France
  • French companies with no site in Hauts-de-France
  • Hauts-de-France companies with a succession plan
  • Foreign-owned companies in Hauts-de-France with a development project
Our services are not intended for :
  • French or international self-employed entrepreneurs
  • French companies wishing to export
  • International companies seeking distribution networks only

Why as the help of Nord France Invest?

Nord France Invest provides you with completely tailored, free of charge and confidential support. We centralize all the information you need to analyze your project. We facilitate your process to find a site, partners or land. We organize site visits. We accelerate your networking with future regional partners. Find out more about the agency's services on this page.

What type of project can support you in?

The agency supports job-creating investment projects. The nature of projects varies according to 3 main categories:
  • Start-up projects
  • Expansion of existing sites in the region
  • takeovers of regional businesses by international companies.
Nord France Invest's services are not aimed at capital investments.
Check the FAQ

Do you have an expansion project?

Leave us your contact details and we’ll get back to you by e-mail.

This field is for validation purposes and should be left unchanged.
Top !
HomeNewsInovet invests €26M in Hauts-de-France

Inovet invests €26M in Hauts-de-France

Inovet France: €26M investment in five years

“New developments and international demand will increase the need for production capacity.” Veterinary pharmaceutical company Biovet (part of the Belgian group Inovet), located in Arques in Hauts-de-France, will benefit from a new investment of 26 million euros. The funds, which will be released in four phases, should enable the plant to be modernised to triple its production capacity. Inovet’s aim is to be ranked among the world’s top 50 animal health companies (livestock and domestic) by 2024.

  • Phase 1: Reconstruction of a new production unit and additional offices.
  • Phase 2: 2019-2021: creation of an injectable preparations unit and construction of a second production line.
  • Phase 3 – 2023: renovation of the water-soluble powders unit.
  • Phase 4 – 2023: optimisation of the site’s logistics.

The company also plans to increase its workforce to implement this policy of increased production. Some 60 people are expected to be recruited by 2023, increasing the site’s workforce to 170 employees.

Biové, the Inovet group’s biggest production site

Inovet has three sites in Europe:

  • Arques in Hauts-de-France (a site acquired in 2007), the group’s largest production site currently employing 110 people (170 by 2023)
  • Belgium, for small production runs (51 employees)
  • Hungary (two employees)

Although the group considered the possibility of relocating production, it finally made the choice to maintain its plant in Hauts-de-France. This is a strategic decision that allows the company:

  • to retain the qualified workforce already employed at the site
  • to benefit from the strategic position of the region at the heart of Europe – 80% of the group’s production sold in France and abroad comes from the Biové plant.

This is a project supported by Nord France Invest (in particular the financial engineering side) and its partners: Conseil Régional Hauts-de-France, CGET, CAPSO and SOFIE. Find out what services we offer to foreign companies!

Discover other
articles about